We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.33%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$54.8B
AUM Growth
+$4.24B
(+8.4%)
Cap. Flow
-$502M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
29.94%
Holding
1,776
New
37
Increased
449
Reduced
1,142
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$158M |
| 2 |
Uber
UBER
|
+$110M |
| 3 |
Blackstone Secured Lending
BXSL
|
+$97.3M |
| 4 |
Amazon
AMZN
|
+$76.3M |
| 5 |
PayPal
PYPL
|
+$75.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$184M |
| 2 |
Crown Castle
CCI
|
+$173M |
| 3 |
CME Group
CME
|
+$125M |
| 4 |
Gilead Sciences
GILD
|
+$119M |
| 5 |
Amgen
AMGN
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.81% |
| 2 | Healthcare | 15.16% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
The Bancorp
TBBK
$2.86B
| $779K | ﹤0.01% |
23,276
-1,174
| -5% | -$46.7K |
|
|
IBTX
1477
DELISTED
Independent Bank Group, Inc.
IBTX
| $778K | ﹤0.01% |
17,050
-860
| -5% | -$40.1K |
|
1478
Certara
CERT
$1.23B
| $777K | ﹤0.01% |
43,477
-2,193
| -5% | -$37.8K |
|
1479
QuidelOrtho
QDEL
$1.14B
| $776K | ﹤0.01% |
16,193
-817
| -5% | -$47.6K |
|
|
SVC
1480
Service Properties Trust
SVC
$1.09B
| $775K | ﹤0.01% |
22,855
-1,153
| -5% | -$42.8K |
|
1481
Huazhu Hotels Group
HTHT
$13.2B
| $774K | ﹤0.01% |
20,000
| – | – |
|
1482
Preferred Bank
PFBC
$1.25B
| $771K | ﹤0.01% |
10,043
-507
| -5% | -$36.7K |
|
|
CPRX
1483
DELISTED
Catalyst Pharmaceutical
CPRX
| $768K | ﹤0.01% |
48,160
-2,430
| -5% | -$36.6K |
|
1484
Rhythm Pharmaceuticals
RYTM
$7.41B
| $765K | ﹤0.01% |
17,659
-891
| -5% | -$39K |
|
1485
Phinia Inc
PHIN
$2.98B
| $765K | ﹤0.01% |
19,906
-1,004
| -5% | -$32.7K |
|
|
INVX
1486
Innovex International
INVX
$1.79B
| $762K | ﹤0.01% |
33,808
-1,705
| -5% | -$37.3K |
|
1487
Cable One
CABO
$249M
| $762K | ﹤0.01% |
1,800
-91
| -5% | -$44.8K |
|
1488
GFL Environmental
GFL
$14.1B
| $762K | ﹤0.01% |
21,500
| – | – |
|
1489
LeMaitre Vascular
LMAT
$2.34B
| $761K | ﹤0.01% |
11,471
-579
| -5% | -$35.7K |
|
1490
Deluxe
DLX
$1.25B
| $761K | ﹤0.01% |
36,961
-1,865
| -5% | -$37.1K |
|
1491
Trustmark
TRMK
$2.74B
| $757K | ﹤0.01% |
26,940
-1,359
| -5% | -$36.7K |
|
1492
StoneX
SNEX
$8.99B
| $756K | ﹤0.01% |
36,305
-1,833
| -5% | -$36.7K |
|
1493
Viavi Solutions
VIAV
$8.66B
| $753K | ﹤0.01% |
82,800
-4,177
| -5% | -$41K |
|
1494
Northwest Bancshares
NWBI
$2.33B
| $750K | ﹤0.01% |
64,360
-3,247
| -5% | -$38.5K |
|
1495
Driven Brands
DRVN
$2.47B
| $749K | ﹤0.01% |
47,456
-2,394
| -5% | -$33.1K |
|
1496
Vitesse Energy
VTS
$626M
| $747K | ﹤0.01% |
31,498
-1,589
| -5% | -$34.9K |
|
|
RC
1497
Ready Capital
RC
$261M
| $744K | ﹤0.01% |
81,470
-4,110
| -5% | -$38.1K |
|
1498
Ironwood Pharmaceuticals
IRWD
$626M
| $744K | ﹤0.01% |
85,392
-4,308
| -5% | -$52.3K |
|
1499
Navient
NAVI
$822M
| $744K | ﹤0.01% |
42,733
+103
| +0.2% | +$1.74K |
|
1500
Pathward Financial
CASH
$1.87B
| $743K | ﹤0.01% |
14,718
-742
| -5% | -$37.7K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Ensign Peak Advisors held 1,776 positions worth $54.8B, up 8.4% from $50.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 5%. Ensign Peak Advisors opened 37 new positions and exited 51, leaving the 1,776-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2024 buy was Blackstone Secured Lending: 3,319,725 shares worth $103M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2024, an estimated $158M increase.
- Ensign Peak Advisors's biggest Q1 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $184M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $66.5M.
- Ensign Peak Advisors's ten largest holdings make up 30% of its $54.8B portfolio in Q1 2024.
- Ensign Peak Advisors opened 37 new positions and closed 51 in Q1 2024.
- Ensign Peak Advisors's portfolio value rose 8.4% quarter-over-quarter to $54.8B.
Based on Ensign Peak Advisors's 13F filing for Q1 2024, filed 14 May 2024.